Bioanalysis Zone

Protein and Peptide Therapeutics: Addressing bioanalytical demands of complicated peptides

0

This is the 3rd presentation in a brand new series of 4 webinars brought to you by Bioanalysis and Waters Corporation on ‘Opportunities in a Changing Landscape: Innovative LC/MS Solutions that will Usher in the Future of DMPK.’

In this webinar Erin Chambers, Principal Applications Chemist at Waters discussed ‘Protein and Peptide Therapeutics: Addressing bioanalytical demands of complicated peptides’

We hope you enjoy this presentation and if you have any questions for the speakers or host please do contact us by emailing info@bioanalysis-zone.com.

The webinar series will tackle 4 important topics facing the DMPK laboratory today that you don’t want to miss! Other webinars in this series include:

The Analysis of Teriparatide by LC-MS/MS – The Challenges and Lessons Learned presented by Elizabeth Thomas, Vice President and General Manager UK Bioanalytical Operations at ICON.

The Shining Future of Accurate Mass Quantitation for Small and Large Molecules presented by Chris Evans, Pharmaceuticals Director at GlaxoSmithKline

Innovation is not dead in DMPK – New platforms that deliver the future for Pharma presented by Mark Wrona, Principal Applications Chemist at Waters

 

Share:

Leave A Comment